SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)
SUROCO
1 other identifier
observational
318
1 country
1
Brief Summary
Overall mortality of COVID-19 is variable and has been reported to be between less than 1% and 7%. Many authors around the world also reported data on hospitalization rate, need for intensive care unit (ICU) care and need for mechanical ventilation in SARS-CoV-2 infected patients. To provide anesthetic and surgical care to SARS-CoV-2 infected patients, many health workers have to organize surgical platforms, personal protections and in-hospital trajectories to prevent dissemination and cross-contamination. However, no data has been published on the surgical need of these patients, their postoperative outcomes and the impact they may have on the operating room. Postoperative outcomes in SARS-CoV-2 infected patients seem to be variable. Expected benefits from a surgical procedure may be different in this population if their postoperative mortality is higher than expected. The association between preoperative characteristics and postoperative outcomes in this population has to be better defined. There is a need to better quantify these and better inform use of surgical resources during a pandemic. To address this knowledge gap, the investigators propose to conduct a multicenter observational cohort study in SARS-CoV-2 infected patients undergoing a surgical procedure, as well as in those who have recovered from COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2020
CompletedFirst Submitted
Initial submission to the registry
June 26, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2022
CompletedJuly 12, 2022
September 1, 2021
2 years
June 26, 2020
July 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital survival
Survival was calculated from the date of participant randomization to the date of participant death due to any cause. If the participant was discharged from the hospital and not seen afterwards, the date of hospital discharge was entered as the last day seen alive.
30 days post-operation
Secondary Outcomes (12)
Occurrence of postoperative respiratory complications
30 days post-operation
Occurrence of postoperative non-pulmonary infectious complications
30 days post-operation
Occurrence of acute kidney injury (AKI)
30 days post-operation
Occurrence of postoperative thromboembolic complications
30 days post-operation
The need for a new postoperative ICU admission
30 days post-operation
- +7 more secondary outcomes
Study Arms (1)
SARS-CoV-2 patients undergoing a surgical procedure
The investigators propose to conduct a prospective observational cohort study on all patients suspected or confirmed being infected to SARS-CoV-2, or recovered from SARS-CoV-2, undergoing a surgery.
Eligibility Criteria
All patients (children and adults) confirmed being infected to SARS-CoV-2 will be included, as well as patients who have recovered, undergoing a surgical procedure in designated Canadian Centers. The investigators will include all patients up to 30th day of April 2021.
You may qualify if:
- all patients undergoing a surgery with either a SARS-CoV-2 clinical suspicion based on reported symptoms during the pandemic (fever, myalgia, fatigue, cough, dyspnea, respiratory failure, diarrhea, vomiting, abdominal pain) or without any suggestive symptoms AND a SARS-CoV-2 confirmed infection with RT-PCR before surgery or within 72 hours after surgery. Patients who have recovered from SARS-CoV-2 infection will also be included. All patients up to 30th day of April 2021 will be included.
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre hospitalier de l'Université de Montréal (CHUM)lead
- Maisonneuve-Rosemont Hospitalcollaborator
- Centre de recherche du Centre hospitalier universitaire de Sherbrookecollaborator
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montrealcollaborator
- St. Justine's Hospitalcollaborator
- Institut de Cardiologie de Montréalcollaborator
- McGill University Health Centre/Research Institute of the McGill University Health Centrecollaborator
- CHU de Quebec-Universite Lavalcollaborator
- Institut universitaire de cardiologie et de pneumologie de Québec, University Lavalcollaborator
Study Sites (1)
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, H2X 3E4, Canada
Related Publications (2)
Amzallag E, Panchadsaram T, Girard M, Lecluyse V, Couture E, D'Aragon F, Kandelman S, Turgeon AF, Jodoin C, Beaulieu P, Richebe P, Carrier FM. Pulmonary complications and mortality among COVID-19 patients undergoing a surgery: a multicentre cohort study. BMJ Open. 2024 Nov 21;14(11):e090158. doi: 10.1136/bmjopen-2024-090158.
PMID: 39578040DERIVEDCarrier FM, Amzallag E, Lecluyse V, Cote G, Couture EJ, D'Aragon F, Kandelman S, Turgeon AF, Deschamps A, Nitulescu R, Djade CD, Girard M, Beaulieu P, Richebe P. Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study. BMC Anesthesiol. 2021 Jan 12;21(1):15. doi: 10.1186/s12871-021-01233-9.
PMID: 33435887DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François-Martin Carrier, MD, FRCPC
Centre hospitalier de l'Université de Montréal (CHUM)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2020
First Posted
July 7, 2020
Study Start
March 13, 2020
Primary Completion
March 13, 2022
Study Completion
April 13, 2022
Last Updated
July 12, 2022
Record last verified: 2021-09